Table 2.

Interview guide (questions adapted to each partner country)

What are the key changes, policies, innovations in self‐care support and diabetes type 2 over the last 10 years? Why have these been the most important ones? What changes have these led to? Why do you think policy has changed in the way that it has? Who are the most important stakeholders in this area? How have they influenced the agenda around self‐care support? What is the role of drug companies nationally/internationally? Do you have a view of current policy around the role of drug companies or how they influence the agenda in this area? What is the role of telecare companies? What is the involvement of other private companies in self‐care support? How is the broader health‐care system organized? What are the public attitudes to self‐care support and diabetes type 2? What are the media constructions of the epidemic of diabetes type 2 and who is at risk?